CN107875115B - 一种分段式可分离微针及其制备方法 - Google Patents
一种分段式可分离微针及其制备方法 Download PDFInfo
- Publication number
- CN107875115B CN107875115B CN201711012832.5A CN201711012832A CN107875115B CN 107875115 B CN107875115 B CN 107875115B CN 201711012832 A CN201711012832 A CN 201711012832A CN 107875115 B CN107875115 B CN 107875115B
- Authority
- CN
- China
- Prior art keywords
- microneedle
- drug
- needle head
- needle
- separable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 74
- 229940079593 drug Drugs 0.000 claims abstract description 57
- 239000000017 hydrogel Substances 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 16
- 239000000758 substrate Substances 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 12
- 239000002131 composite material Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 7
- 238000001723 curing Methods 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 229960004329 metformin hydrochloride Drugs 0.000 claims description 5
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 claims description 5
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims description 5
- 229920001610 polycaprolactone Polymers 0.000 claims description 5
- 239000004632 polycaprolactone Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000013271 transdermal drug delivery Methods 0.000 abstract description 6
- 229920000642 polymer Polymers 0.000 abstract description 5
- 230000000717 retained effect Effects 0.000 abstract description 4
- 230000009545 invasion Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 10
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 10
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 10
- 239000001768 carboxy methyl cellulose Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 6
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 6
- -1 polydimethylsiloxane Polymers 0.000 description 6
- 229920000747 poly(lactic acid) Polymers 0.000 description 5
- 239000004626 polylactic acid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 238000002679 ablation Methods 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000013270 controlled release Methods 0.000 description 3
- 239000008177 pharmaceutical agent Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010074864 Factor XI Proteins 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229920000891 common polymer Polymers 0.000 description 1
- 238000013267 controlled drug release Methods 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000009489 vacuum treatment Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711012832.5A CN107875115B (zh) | 2017-10-26 | 2017-10-26 | 一种分段式可分离微针及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711012832.5A CN107875115B (zh) | 2017-10-26 | 2017-10-26 | 一种分段式可分离微针及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107875115A CN107875115A (zh) | 2018-04-06 |
CN107875115B true CN107875115B (zh) | 2021-08-03 |
Family
ID=61782414
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711012832.5A Active CN107875115B (zh) | 2017-10-26 | 2017-10-26 | 一种分段式可分离微针及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107875115B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019227156A1 (en) * | 2018-05-30 | 2019-12-05 | The University Of Sydney | Microneedle arrays and uses thereof |
CN110870943A (zh) * | 2018-08-31 | 2020-03-10 | 中科微针(北京)科技有限公司 | 一种可植入型两段式微针贴片及其制备方法 |
CN109364017B (zh) * | 2018-09-03 | 2022-04-01 | 中山大学 | 快速分离型可溶性微针及其制备方法 |
CN110812688B (zh) * | 2019-11-20 | 2020-12-01 | 广州中医药大学(广州中医药研究院) | 一种透皮给药的微针及其制备方法 |
CN111956596A (zh) * | 2020-08-13 | 2020-11-20 | 华中科技大学 | 一种响应性释放药物微针贴片及其制备方法 |
CN112842989B (zh) * | 2021-01-20 | 2023-04-11 | 浙江理工大学 | 一种负载铜离子掺杂聚多巴胺的微针贴片及其制备方法、应用 |
CN115154883B (zh) * | 2022-07-27 | 2024-05-03 | 武汉理工大学三亚科教创新园 | 一种可更换载药储层的水凝胶微针及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107096013A (zh) * | 2017-06-09 | 2017-08-29 | 广州新济薇娜生物科技有限公司 | 鲑鱼降钙素可溶性微针贴片及其制备方法 |
-
2017
- 2017-10-26 CN CN201711012832.5A patent/CN107875115B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107096013A (zh) * | 2017-06-09 | 2017-08-29 | 广州新济薇娜生物科技有限公司 | 鲑鱼降钙素可溶性微针贴片及其制备方法 |
Non-Patent Citations (1)
Title |
---|
Near-Infrared Light-Activatable Microneedle System for Treating Superficial Tumors by Combination of Chemotherapy and Photothermal Therapy;Mei-Chin Chen等;《ACS Nano》;20151123;第10卷;第93-101页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107875115A (zh) | 2018-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107875115B (zh) | 一种分段式可分离微针及其制备方法 | |
KR101747099B1 (ko) | 생체적합성 고분자를 이용한 마이크로니들의 제조방법 | |
CN108245482B (zh) | 一种可程序性释放药物的聚合物复合微针及其制备 | |
CN109364017B (zh) | 快速分离型可溶性微针及其制备方法 | |
Nayak et al. | Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine | |
EP3761864B1 (en) | Method of manufacturing a microneedle assembly | |
CN104069585A (zh) | 可分离式微针系统及其制造方法 | |
CN110917176A (zh) | 一种可植入型缓释微针贴片及其制备方法 | |
KR20170077809A (ko) | 경피 흡수용 마이크로구조체 및 이의 제조방법 | |
CN105854172A (zh) | 微结构体的制造方法 | |
JP2011224332A (ja) | 経皮吸収シート及びその製造方法 | |
CN110478612B (zh) | 尖端溶解法制备气泡式空心给药微针的方法 | |
CN116617551A (zh) | 一种微针装置 | |
CN204352374U (zh) | 一种可分离式微针系统 | |
WO2021244630A1 (zh) | 一种耐热型可植入式聚合物微针及其制备方法和应用 | |
KR102249834B1 (ko) | 마이크로 니들 패치의 제조 방법 | |
CN106619480A (zh) | 一种新型聚合物微针阵列及其制备方法 | |
Starlin Chellathurai et al. | Biodegradable polymeric insulin microneedles–a design and materials perspective review | |
CA3155522A1 (en) | Methods for making microneedles using adjustment of component solubility in casting formulations | |
KR102227989B1 (ko) | 미세 구조체 기반 약물 주입장치 및 이의 제조 방법 | |
KR102320528B1 (ko) | 생리활성물질 피부 전달용 마이크로 구조체 제조방법 | |
CN113440474B (zh) | 一种高载药量高柔韧性的多孔微针材料及其制备方法 | |
KR102248363B1 (ko) | 생리활성물질 피부 전달용 마이크로 구조체 제조방법 | |
CN114177512A (zh) | 一种逐层沉积抗菌促愈可溶性微针贴片及其制备方法 | |
TWI645870B (zh) | 經皮吸收用微結構體及其製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220714 Address after: 401320 Banan District, Banan District, Chongqing, No. 8-29, Yu Nan Road, No. 8-29 Patentee after: Chongqing Boshi Intellectual Property Service Co.,Ltd. Address before: 310018 No. 928, No. 2 Avenue, Baiyang Street, Hangzhou Economic and Technological Development Zone, Hangzhou City, Zhejiang Province Patentee before: ZHEJIANG SCI-TECH University Effective date of registration: 20220714 Address after: 201400 room 1796, building 6, 1150 Lanfeng Road, Fengxian District, Shanghai Patentee after: Shanghai Ranwei Medical Technology Co.,Ltd. Address before: 401320 Banan District, Banan District, Chongqing, No. 8-29, Yu Nan Road, No. 8-29 Patentee before: Chongqing Boshi Intellectual Property Service Co.,Ltd. |
|
TR01 | Transfer of patent right |